FactSet Research Systems Inc.

Executive Summary

SELL, Medium conviction. FDS rates SELL, Medium conviction. The company just posted a better quarter, with ASV +7.1%, revenue +6.4%, and management saying FY26 revenue and EPS are tracking to the high end of guidance, but that improvement is already offset by a valuation still above peers, a ~300 bps YoY margin step-down, and a quant base-case price target of $222.37, or -10.0% from the current $247.11. The setup is less attractive because the stock has already recovered off the lows, up 7.1% in 3 months, while the fundamental upside still depends on AI monetization outrunning AI-driven pricing risk.

Investment Thesis

FDS is not a broken business. It is a solid business with a live AI opportunity, but the stock still looks too expensive for the actual earnings path investors are buying. FY2025 revenue was $2.3B, up 3.6%, and EPS was $15.74, up 5.6%. That is respectable, not exciting. Yet the stock still trades at 16.18x earnings and 3.73x sales, both above peer averages of 14.3x and 1.7x. When growth is mid-single-digit and margins are slipping, paying a premium multiple requires confidence that the next leg of growth is both durable and high-return. That confidence is not there yet.

The strongest argument against a negative call is the recent operating trend. Q3 FY26 was clearly better. ASV grew 7.1%, the fifth straight quarter of acceleration. Revenue rose 6.4%, adjusted EPS was $4.53, and management said revenue and EPS are tracking toward the high end of FY26 guidance. AI is also becoming tangible rather than conceptual. Over 10% of ASV growth came directly from AI SKUs, 450+ clients are engaged with MCP, and API volume rose 13x versus Q2. Those are real signals that FactSet can monetize AI and deepen integration rather than simply absorb higher compute and product costs.

The problem is that the income statement still shows friction. Adjusted operating margin in Q3 was 34%, below the year-ago level, and EBITDA margin of 35.6% was down 610 bps YoY. Management cited targeted investments, incentive compensation, and 60 bps of FX hedge drag, plus a ~10% tech workforce reduction tied to AI-assisted coding productivity. That cost reset may help later, but today investors are being asked to pay for future margin recovery that has not shown up yet. Even on FY2025 numbers, operating margin fell to 31.3% from 31.8%.

The case therefore depends on three things. First, ASV growth must stay near the current 7.1% pace into FY27. Second, AI revenue must scale faster than AI commoditizes desktop, search, and workflow value. Third, margin recovery must follow the productivity story. If those happen, downside is limited and the stock can work. If they do not, FDS drifts toward the engine's $222.37 base case or lower. With the shares already up from the $185.00 low and only 1.0% below the 200-day average, the setup no longer offers enough asymmetry to own through that uncertainty.

Key Metrics

Financial Strength

FDS remains financially sound, but the balance sheet is no longer a differentiator. Leverage at 1.63x debt/EBITDA is manageable for a subscription-heavy data business, and the company still converts earnings into meaningful cash, with $0.3B of FCF in FY2025 and a very high 94 cash-flow-quality score. The issue is that liquidity is only fair, with a 0.68 current ratio, and profitability is drifting rather than expanding, shown by FY2025 operating margin down to 31.3% and Q3 FY26 margin compression despite better revenue growth. That leaves the company able to fund buybacks and investment, but with less room for valuation forgiveness if execution slips.

Competitive Position

FactSet's moat comes from embedded workflow, integrated content, and switching costs inside investment and wealth workflows. Clients do not just buy raw data, they buy an operating layer tied to models, APIs, research, screening, and advisor desktops, which helps explain longer contract terms and management's statement that there is no price compression on renewals. Durability is good but not untouchable: AI strengthens the moat if FactSet owns the workflow and packaging, but weakens it if model providers turn premium interfaces into commodity access points for underlying data.

Management & Guidance

Management's latest message is incrementally positive but not forceful enough to override valuation. On the Q3 FY26 call, the company reiterated FY26 ranges for ASV, revenue, operating margin, and EPS, while saying revenue and EPS are tracking toward the high end. CFO Joshua Warren said, "On our outlook — we remain confident in the guidance ranges previously set for ASV, revenue, operating margin and EPS. On revenue and EPS in particular, we are tracking toward the high end of those ranges based on our business trajectory." That is supportive, especially with CEO Sanoke Viswanathan adding, "The momentum continues into Q4. Just a month into the quarter, we see continued momentum." The credibility is decent because FDS has beaten EPS in 6 of the last 8 quarters and just posted its strongest ASV growth since early 2024, but the fact that guidance was not formally raised despite those signals suggests management still sees enough Q4 execution risk to stay conservative.

Segment Analysis

• Product and segment mix (Not disclosed in provided data): Historical call data flagged wealth management as the strongest area, with 12% organic ASV growth in FY24 and over 23,000 advisor desktops added.
• Geographic revenue (Not disclosed in provided data): Q3 FY26 ASV growth of 7.1% was described as broad-based across all regions and client types.
• AI-related SKUs (Over 10% of Q3 ASV growth): This is the clearest current growth vector, supported by 450+ client engagements and 13x API volume growth vs Q2.

Capital Allocation

Capital allocation looks disciplined but not especially aggressive. FY2025 FCF was $0.3B, with $0.2B used for buybacks, and management said more than $625M had been returned to shareholders YTD in FY26. The concern is not recklessness, it is that modest cash generation relative to an $8.4B market cap and a $1.6B debt load limits how much capital returns alone can drive the equity if growth and margins do not improve further.

Management Execution & Track Record

Execution has been mixed but recently improved. On the 2024 Q4 call, management guided FY25 to 4%-6% organic ASV growth, 36%-37% adjusted operating margin, and $16.80-$17.40 adjusted EPS, while signaling a softer first half and stronger second half. What actually followed was less impressive on margins and earnings growth: FY2025 revenue reached $2.3B, up 3.6%, EPS was $15.74, up 5.6%, and operating margin was only 31.3%, well below the prior FY24 adjusted margin reference of 37.8% and below the FY25 guide framework discussed two years ago. That said, management did deliver the acceleration they promised directionally: Q3 FY26 marked the fifth consecutive quarter of organic ASV acceleration, reaching 7.1%, and recent EPS execution improved with 3 straight beats. Strategy has not changed materially, but the center of gravity has shifted from hoping GenAI adds 30-50 bps to growth in FY25 to showing that AI already contributes over 10% of ASV growth in Q3 FY26. Credibility is decent on growth direction, weaker on margin preservation.

Positioning & Flows

Ownership is crowded and institutional, with the top three institutions holding 78.9%, while insiders own only 1.1%. Short interest is elevated at 14.95%, or 5.3M shares, with 5.5 days-to-cover, which can support squeezes around earnings but also signals real skepticism about the durability of the recent AI-led rebound. Near-dated options positioning is mildly supportive because gamma is positive and zero-gamma sits at $213.71, below spot, which can dampen downside mechanically, but that is a trading cushion, not a fundamental thesis.

Bull Case

• Fifth consecutive quarter of organic ASV acceleration culminated in 7.1% growth in Q3 FY26, the strongest pace since Q1 2024 and broad-based across regions and client types.
• AI monetization is real, not just narrative: management said over 10% of ASV growth in Q3 came directly from AI SKUs, with 450+ clients engaged with MCP and API volume up 13x vs Q2.
• Execution has improved in recent quarters: FDS beat Street EPS in 6 of the last 8 reported quarters, including +2.0%, +1.8%, and +3.4% in the last three reports.
• Contracting trends are favorable: management said there is "not taking any price compression in return for contract extensions", and average contract term extended roughly 30%.

Bear Case

• Growth still looks modest against the valuation: FY2025 revenue rose just 3.6% to $2.3B, EPS rose 5.6% to $15.74, yet the stock trades above peer P/E and more than double peer P/S.
• Margins are going the wrong way: FY2025 operating margin fell to 31.3% from 31.8%, and Q3 FY26 adjusted operating margin of 34% was below the year-ago level, with EBITDA margin down 610 bps YoY to 35.6%.
• Guidance was not raised despite the strong Q3, even though management said revenue and EPS are tracking toward the high end. That restraint matters with the next catalyst still 68 days away.
• Balance-sheet flexibility is adequate, not pristine: debt is $1.6B, debt/EBITDA 1.63x, debt/equity 0.77, current ratio 0.68, and financial health scores only 42/100.

Valuation & Price Target

Engine price target $222.37 (-10% vs current), Medium confidence.

• P/E Multiple: $220.11 (28% weight)
• P/S Multiple: $115.53 (20% weight)
• Quality-adjusted: $277.55 (20% weight)
• DCF: $432.7 (5% weight)

The rating stays aligned with the quant baseline SELL. The core reason is simple: the engine's $222.37 target implies -10.0% downside from $247.11, and the underlying business, while improving, still does not earn a premium enough to offset that gap. FDS is trading at 16.18x P/E versus a peer average of 14.3x, with wide peer dispersion of 11.2x making comparables imperfect, but even allowing for quality, FY2025 growth was only 3.6% on revenue and 5.6% on EPS, while margins compressed to 31.3% and Q3 EBITDA margin was down 610 bps YoY. The bullish rebuttal is real, AI monetization, 450+ clients, 13x API volume, and high-end guidance tracking, but management still did not raise the range. Sell-side consensus also skews Sell, but that is only a context check, not the basis for the call.

Risk Assessment

Risk score 58/100 (Moderate). The biggest risk to a SELL is that AI products turn today's 7.1% ASV growth into a sustained mid-to-high single-digit revenue/EPS trajectory, making 16.18x P/E look too cheap rather than too expensive.

The Bottom Line

FDS rates SELL, Medium conviction. The business is executing better, and AI traction is real, but the stock still prices in more durability and margin recovery than the current numbers justify. The base case remains the engine target of $222.37, which implies -10.0% downside from $247.11. A move to neutral would require either a cleaner margin recovery path or a formal guidance raise that proves Q3 was not just a good quarter. A move to bullish would need evidence that AI can sustain 7%+ growth without eroding pricing power.